June 2, 2020 / 12:57 PM / a month ago

BRIEF-La Jolla Says Board Approved Restructuring Plan To Align Organization With Focus On Commercialization Of Giapreza

June 2 (Reuters) - La Jolla Pharmaceutical Co:

* LA JOLLA PHARMACEUTICAL CO - ON MAY 28, BOARD APPROVED RESTRUCTURING PLAN TO ALIGN ORGANIZATION WITH SOLE FOCUS ON COMMERCIALIZATION OF GIAPREZA

* LA JOLLA PHARMACEUTICAL CO - ESTIMATES THAT CO WILL INCUR EXPENSES OF ABOUT $4.1 MILLION IN Q2 RELATED TO RESTRUCTURING OF CO

* LA JOLLA PHARMACEUTICAL CO - IN CONNECTION WITH RESTRUCTURING, DENNIS MULROY AND JAMES ROLKE TO LEAVE CO, EFFECTIVE MAY 31

* LA JOLLA PHARMACEUTICAL CO - EFFECTIVE JUNE 1, APPOINTED MICHAEL HEARNE AS CO'S CFO Source text: (bit.ly/3dsiALM) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below